News

QualTex Laboratories, a subsidiary of BioBridge, offers a variety of ways for you to stay connected with us and our subsidiaries. You can read our latest press releases or Annual Reports. Visit the Events Page to find out what’s coming up. You can watch a video clip from a newscast, view past events in the Photo Gallery or read industry news. For the social media enthusiast, the BioBridge family is known as “Connect for Life,” and can be found on FacebookTwitterLinkedIn and YouTube. Also, visit our blog here.

Media is welcome to contact the Corporate Communications Department for more information.

We offer:

  • 
Interviews with experts in their respective medical fields
  • Interviews with Life Links - community members touched by the services of BioBridge Global
  • Informative tours of the facility

Please contact;
Corporate Communications
Phone: (210) 731-5519
Mobile: (210) 296-9026
Email: crd@biobridgeglobal.org

Recent News Articles

Tests help identify potential convalescent plasma donors
June 17, 2020

QualTex Laboratories is up and running with two assays to detect the presence of COVID-19 antibodies in the bloodstream.

QualTex Laboratories, a subsidiary of nonprofit BioBridge Global, has been performing the SARS-CoV-2 IgG Antibody ELISA assay since April. A second assay, the Abbott Laboratories Architect Antibody assay, went into full-scale production for a QualTex customer on June 8.

“These two assays are part of our continuing commitment to public health,” said Ward Carter, Chief Operating Officer of QualTex Laboratories. “They give blood centers the information to potentially save lives during the COVID-19 pandemic by helping to identify potential COVID-19 convalescent plasma donors.”

Community blood center offering test over summer
June 6, 2020

To thank donors for coming out to give, the South Texas Blood & Tissue Center (STBTC) will provide COVID-19 antibody testing for all blood donations this summer, from June 8 - Aug. 31. Test results will be mailed to donors within 14 days of their donations, which are by appointment only.

QualTex Laboratories, which like STBTC is a subsidiary of San Antonio-based nonprofit BioBridge Global, will perform the tests. Results will show if the donor has been exposed to the virus that causes COVID-19 by looking for antibodies the immune system produces in response to the virus.

The antibody test is not a diagnostic test and is not intended for people who are experiencing COVID-19 symptoms or believe they may be infected, since it does not test directly for the virus. Anyone with symptoms is asked to remain home and to contact his or her physician.

Recognition due to advancing large-scale manufacturing capabilities for clinical-grade adult stem cells for research and new therapies
March 10, 2020
80L-bioreactor-stemcells

BioBridge Global has been named one of two Prototype of the Year Award winners by the Medical Technology Enterprise Consortium (MTEC) for work done following a $7.8 million MTEC grant for the development of large-scale manufacturing capabilities for clinical-grade adult stem cells.

The award was presented at the MTEC Annual Meeting on March 4.

“This award recognizes flawless execution – on-time or ahead of schedule and on-budget for all milestones,” said Becky Cap, Chief Operating Officer of GenCure. “Getting to this point with four collaborators is a huge acknowledgement of excellence both for our execution teams and the supporting groups who worked through billing and reporting requirements.”

Second location gives QualTex largest automated testing capability in the United States
February 26, 2020

QualTex Laboratories, a subsidiary of San Antonio-based nonprofit BioBridge Global, has begun testing blood and plasma donations on its second automated track system, expanding its capabilities in its San Antonio laboratory.

The Abbott Accelerator a3600 Laboratory Automation System is just the third installed at a donor testing facility in the United States. There also is one at the QualTex Laboratories facility in Norcross, Georgia. The combined systems give QualTex Laboratories the largest automated testing setup in the country.

Ward Carter, Chief Operating Officer of QualTex Laboratories, said the addition of the automation system in San Antonio benefits both customers and staff.

Just One Month After Announcement, QualTex Implements Changes
August 22, 2018
zika-test-update-qualtex

QualTex Laboratories is up and running with new guidance for testing blood donations for the Zika virus, just weeks after the Food and Drug Administration issued revised recommendations for blood centers.

In July, the FDA distributed a Guidance for Industry permitting the use of “minipool” testing for Zika, in which samples from a small group of donors are combined and tested for the presence of Zika virus antibodies. Since Zika testing began in 2016, all donations had been required to be tested individually.

The new minipool Zika method began at QualTex Laboratories facilities in San Antonio and Norcross, Georgia, on Aug. 16. QualTex performs blood testing for the South Texas Blood & Tissue Center (STBTC), as well as blood and plasma centers throughout the United States.

Pages